Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy.
Pabst T, Vey N, Adès L, Bacher U, Bargetzi M, Fung S, Gaidano G, Gandini D, Hultberg A, Johnson A, Ma X, Müller R, Nottage K, Papayannidis C, Recher C, Riether C, Shah P, Tryon J, Xiu L, Ochsenbein AF.
Pabst T, et al. Among authors: riether c.
Haematologica. 2023 Jul 1;108(7):1793-1802. doi: 10.3324/haematol.2022.281563.
Haematologica. 2023.
PMID: 36779592
Free PMC article.
Clinical Trial.